These results show that the level of Asn88-free RNase1 was significantly decreased in sera from patients with PaCa, supporting the hypothesis that N-glycosylation at Asn88 of serum RNase1 was significantly increased in the patients with PaCa. This evidence concerns the gene RNASE1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.